-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-knee-physical-therapy_executive.pdf
November 01, 2012 - 1
Comparative Effectiveness Review
Number 77
Physical Therapy Interventions for Knee Pain
Secondary to Osteoarthritis
Executive Summary
Background
Osteoarthritis (OA), the most common
form of arthritis,1 is a progressive joint
disorder characterized by gradual loss
of cartilage.2 Osteoarthritis of the knee …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/decision-models-guidance_methods.pdf
October 01, 2016 - Guidance for the Conduct and Reporting of Modeling and Simulation Studies in the Context of Health Technology Assessment
Methods Guide
for Comparative Effectiveness Reviews
Guidance for the Conduct and Reporting of Modeling
and Simulation Studies in the Context of Health
Technology Assessment
Th…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_executive.pdf
January 01, 2010 - 1
Comparative Effectiveness Review
Number 57
Methods for Insulin Delivery and Glucose
Monitoring: Comparative Effectiveness
Executive Summary
Background
Diabetes mellitus is defined as a group
of metabolic diseases characterized by
hyperglycemia resulting from defects
in insulin secretion from the pancreati…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
September 01, 2013 - 1
Comparative Effectiveness Review
Number 125
Testing of CYP2C19 Variants and Platelet
Reactivity for Guiding Antiplatelet Treatment
Executive Summary
Background
Burden of Disease and Clinical
Setting
Approximately 82 million Americans
currently suffer from some form of
cardiovascular disease.1 In the United …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
January 01, 2025 - Table C-1. KQ 3,4, 5 Char.
Table C-1 Characteristics of included studies KQ 3, KQ 4, and KQ 5
First Author Last Name Year of Publication Citation Study Cohort Name Study Registration Number Related Publications Study Funder Country Study Design Population Narrative Age (years) Eligible Minimum Age Actual Minimum Age …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
January 01, 2025 - Table C-1. KQ 3,4, 5 Char.
Table C-1 Characteristics of included studies KQ 3, KQ 4, and KQ 5
First Author Last Name Year of Publication Citation Study Cohort Name Study Registration Number Related Publications Study Funder Country Study Design Population Narrative Age (Years) Eligible Minimum Age Actual Minimum Age …